Literature DB >> 9889141

Pharmacogenomics - it's not just pharmacogenetics.

D S Bailey1, A Bondar, L M Furness.   

Abstract

New technologies in both combinatorial chemistry and combinatorial biology promise to unlock new opportunities for drug discovery and lead optimisation. Using such genome-based technologies to measure the dynamic properties of pharmacological systems, pharmacogenomics can now provide an objective measure of a drug's biological efficacy, including its potential adverse effects.

Mesh：

Substances：

Year:  1998        PMID： 9889141     DOI： 10.1016/s0958-1669(98)80136-5

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  4 in total

Review 1.  Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.

Authors:  Sandrine de Montgolfier; Grégoire Moutel; Nathalie Duchange; Ioannis Theodorou; Christian Hervé; Catherine Leport
Journal:  Pharmacogenetics       Date:  2002-12

Review 2.  Pharmacogenetics in health-care practice.

Authors:  der Zee Anke-Hilse Maitland-van; Olaf H Klungel; Anthonius de Boer
Journal:  Pharm World Sci       Date:  2004-10

3.  High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies.

Authors:  A Castensson; L Emilsson; P Preece; E E Jazin
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 4.  Pharmacogenetically driven treatments for alcoholism: are we there yet?

Authors:  Albert J Arias; R Andrew Sewell
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.